We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:
Biomedicine

Search Results

Showing 1-20 of 1,067 results

  1. Mitochondrial transfer in hematological malignancies

    Mitochondria are energy-generated organelles and take an important part in biological metabolism. Mitochondria could be transferred between cells,...

    **aodong Guo, Can Can, ... Daoxin Ma in Biomarker Research
    Article Open access 05 October 2023

  2. SWI/SNF complexes in hematological malignancies: biological implications and therapeutic opportunities

    Hematological malignancies are a highly heterogeneous group of diseases with varied molecular and phenotypical characteristics. SWI/SNF...

    Alvaro Andrades, Paola Peinado, ... Pedro P. Medina in Molecular Cancer
    Article Open access 21 February 2023

  3. Risk of hematological malignancies from CT radiation exposure in children, adolescents and young adults

    Over one million European children undergo computed tomography (CT) scans annually. Although moderate- to high-dose ionizing radiation exposure is an...

    Magda Bosch de Basea Gomez, Isabelle Thierry-Chef, ... Elisabeth Cardis in Nature Medicine
    Article Open access 09 November 2023

  4. Cytogenetic culture failure and its causes in hematological disorders; a single centre perspective

    Objective

    To highlight the reasons of culture failure in bone marrow aspirate samples sent for Cytogenetic analysis and to identify the associated...

    Sarah Javed, Jawad Hassan, ... Tahir Sultan Shamsi in Molecular Cytogenetics
    Article Open access 10 February 2023

  5. Flow Cytometry in the Diagnosis of Hematological Neoplasms and Other Cancers

    Flow cytometry (FCM) is a powerful technology that can provide rapid multiparameter analysis of single cells. With the significant improvement in...
    Weijie Li in Handbook of Cancer and Immunology
    Living reference work entry 2023

  6. One-year breakthrough SARS-CoV-2 infection and correlates of protection in fully vaccinated hematological patients

    The long-term clinical efficacy of SARS-CoV-2 vaccines according to antibody response in immunosuppressed patients such as hematological patients has...

    José Luis Piñana, Lourdes Vazquez, ... Rodrigo Martino in Blood Cancer Journal
    Article Open access 05 January 2023

  7. Financial toxicity in hematological malignancies: a systematic review

    Hematologic malignancy outcomes have remarkably improved in the past decade with further advancement expected in future years. However, the...

    Evguenia Ouchveridze, Rahul Banerjee, ... Ghulam Rehman Mohyuddin in Blood Cancer Journal
    Article Open access 22 April 2022

  8. Deubiquitinases in hematological malignancies

    Deubiquitinases (DUBs) are enzymes that control the stability, interactions or localization of most cellular proteins by removing their ubiquitin...

    Hu Lei, Jiaqi Wang, ... Yingli Wu in Biomarker Research
    Article Open access 28 August 2021

  9. Immune biomarkers to predict SARS-CoV-2 vaccine effectiveness in patients with hematological malignancies

    There is evidence of reduced SARS-CoV-2 vaccine effectiveness in patients with hematological malignancies. We hypothesized that tumor and...

    Luis-Esteban Tamariz-Amador, Anna Martina Battaglia, ... Bruno Paiva in Blood Cancer Journal
    Article Open access 14 December 2021

  11. Detection and genetic characterization of feline retroviruses in domestic cats with different clinical signs and hematological alterations

    Feline leukemia virus (FeLV) and feline immunodeficiency virus (FIV) are globally distributed retroviruses that infect domestic cats and cause...

    Gabriel Eduardo Acevedo-Jiménez, Rosa Elena Sarmiento-Silva, ... Hugo Ramírez-Álvarez in Archives of Virology
    Article 19 December 2022

  13. The landscape overview of CD47-based immunotherapy for hematological malignancies

    Extensive clinical and experimental evidence suggests that macrophages play a crucial role in cancer immunotherapy. Cluster of differentiation (CD)...

    Hua Yang, Yang Xun, Hua You in Biomarker Research
    Article Open access 01 February 2023

  14. The emerging landscape of exosomal CircRNAs in solid cancers and hematological malignancies

    Circular RNAs (circRNAs) are a type of recently discovered noncoding RNA. They exert their biological functions by competitively binding to microRNAs...

    Qinfeng Zhou, Dacheng **e, ... Dawei Cui in Biomarker Research
    Article Open access 03 May 2022

  15. When Glycosylation Meets Blood Cells: A Glance of the Aberrant Glycosylation in Hematological Malignancies

    Among neoplasia-associated epigenetic alterations, changes in cellular glycosylation have recently received attention as a key component of...
    Huining Su, Mimi Wang, ... Ying Cheng in Reviews of Physiology, Biochemistry and Pharmacology
    Chapter 2021

  16. Characterizing the polygenic architecture of complex traits in populations of East Asian and European descent

    To investigate the polygenicity of complex traits in populations of East Asian (EAS) and European (EUR) descents, we leveraged genome-wide data from...

    Antonella De Lillo, Frank R. Wendt, ... Renato Polimanti in Human Genomics
    Article Open access 20 July 2023

  17. Hyaluronan in the Extracellular Matrix of Hematological and Solid Tumors. Its Biological Effects

    Tumors are most frequently induced by environmental factors with oncogenic potential. Beside tumor cells, cancer tissue contains several nonmalignant...
    Antonella Icardi, Silvina L. Lompardia, ... Elida Alvarez in The Extracellular Matrix and the Tumor Microenvironment
    Chapter 2022

  19. Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study

    Hairy cell leukemia (HCL) is a rare lymphoproliferative disease with an excellent prognosis after treatment with cladribine (2CDA), although relapse...

    Livio Pagano, Marianna Criscuolo, ... Pier Luigi Zinzani in Blood Cancer Journal
    Article Open access 19 July 2022

  20. T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapy

    We report a T cell lymphoma (TCL) occurring 3 months after anti-CD19 chimeric antigen receptor (CAR) T cell immunotherapy for non-Hodgkin B cell...

    Guido Ghilardi, Joseph A. Fraietta, ... Marco Ruella in Nature Medicine
    Article 24 January 2024
Did you find what you were looking for? Share feedback.